pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 11·1 min read
save

New home for Novo's Parkinson's cell therapy; GSK's deal to sell drug in China

Plus, label expansions for two drugs targeting rare diseases, and Genmab scraps a Phase 1 cancer trial: 🧠 Novo's Parkinson's cell therapy finds a biotech home: Novo Nordisk has found a home for an early-stage ...

May 11, 2026·read at Endpoints ↗

May 11, 2026 11:11 AM EDT News Briefing New home for Novo's Parkin­son's cell ther­a­py; GSK's deal to sell hep B drug in Chi­na ENDPOINTS Plus, la­bel ex­pan­sions for two drugs tar­get­ing rare dis­eases, and Gen­mab scraps a Phase 1 can­cer tri­al: 🧠 No­vo’s Parkin­son’s cell ther­a­py finds a biotech … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
85 words · retrieved May 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVO4Ultragenyx Pharmaceutical Inc.2Novo Nordisk Inc
topics
Cell Therapy2Rare Disease2Monoclonal AntibodyOncology

related stories

  • 21h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Aug 5Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcommsBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • Aug 6Third time’s the charm for Replimune as melanoma drug earns FDA greenlightBioSpace